330 related articles for article (PubMed ID: 29600940)
1. The burden of systemic juvenile idiopathic arthritis for patients and caregivers: an international survey and retrospective chart review.
Shenoi S; Horneff G; Cidon M; Ramanan AV; Kimura Y; Quartier P; Foeldvari I; Zeft A; Lomax KG; Gregson J; Abma T; Campbell-Hill S; Weiss J; Patel D; Marinsek N; Wulffraat N
Clin Exp Rheumatol; 2018; 36(5):920-928. PubMed ID: 29600940
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea.
Buono JL; Carson RT; Flores NM
Health Qual Life Outcomes; 2017 Feb; 15(1):35. PubMed ID: 28196491
[TBL] [Abstract][Full Text] [Related]
3. Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry.
Horneff G; Schulz AC; Klotsche J; Hospach A; Minden K; Foeldvari I; Trauzeddel R; Ganser G; Weller-Heinemann F; Haas JP
Arthritis Res Ther; 2017 Nov; 19(1):256. PubMed ID: 29166924
[TBL] [Abstract][Full Text] [Related]
4. Patients' perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom.
Vo P; Fang J; Bilitou A; Laflamme AK; Gupta S
J Headache Pain; 2018 Sep; 19(1):82. PubMed ID: 30203163
[TBL] [Abstract][Full Text] [Related]
5. Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience.
Barut K; Adrovic A; Sahin S; Tarcin G; Tahaoglu G; Koker O; Yildiz M; Kasapcopur O
Int J Rheum Dis; 2019 Sep; 22(9):1661-1669. PubMed ID: 31273940
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of biological agents for systemic juvenile idiopathic arthritis: a systematic review and meta-analysis of randomized trials.
Tarp S; Amarilyo G; Foeldvari I; Christensen R; Woo JM; Cohen N; Pope TD; Furst DE
Rheumatology (Oxford); 2016 Apr; 55(4):669-79. PubMed ID: 26628580
[TBL] [Abstract][Full Text] [Related]
7. Functional Ability and Health-Related Quality of Life in Randomized Controlled Trials of Tocilizumab in Patients With Juvenile Idiopathic Arthritis.
Brunner HI; Chen C; Bovis F; De Benedetti F; Espada G; Joos R; Akikusa J; Chaitow J; Boteanu AL; Kimura Y; Rietschel C; Siri D; Smolewska E; Schmeling H; Brown DE; Martini A; Lovell DJ; Huang B; Ruperto N;
Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1264-1274. PubMed ID: 32702212
[TBL] [Abstract][Full Text] [Related]
8. Work impairment, osteoarthritis, and health-related quality of life among employees in Japan.
Nakata K; Tsuji T; Vietri J; Jaffe DH
Health Qual Life Outcomes; 2018 Apr; 16(1):64. PubMed ID: 29665820
[TBL] [Abstract][Full Text] [Related]
9. The humanistic and economic burden of juvenile idiopathic arthritis in the era of biologic medication.
Gidman W; Meacock R; Symmons D
Curr Rheumatol Rep; 2015 May; 17(5):31. PubMed ID: 25874347
[TBL] [Abstract][Full Text] [Related]
10. The impact of rheumatoid arthritis on the burden of disease in urban China.
Langley PC; Mu R; Wu M; Dong P; Tang B
J Med Econ; 2011; 14(6):709-19. PubMed ID: 21899486
[TBL] [Abstract][Full Text] [Related]
11. Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe.
Kuhlmann A; Schmidt T; Treskova M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Péntek M; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():79-87. PubMed ID: 27086322
[TBL] [Abstract][Full Text] [Related]
12. A retrospective study on 158 Thai patients with juvenile idiopathic arthritis followed in a single center over a 15-year period.
Vilaiyuk S; Soponkanaporn S; Jaovisidha S; Benjaponpitak S; Manuyakorn W
Int J Rheum Dis; 2016 Dec; 19(12):1342-1350. PubMed ID: 26176300
[TBL] [Abstract][Full Text] [Related]
13. Socioeconomic costs and health-related quality of life in juvenile idiopathic arthritis: a cost-of-illness study in the United Kingdom.
Angelis A; Kanavos P; López-Bastida J; Linertová R; Serrano-Aguilar P;
BMC Musculoskelet Disord; 2016 Aug; 17():321. PubMed ID: 27484740
[TBL] [Abstract][Full Text] [Related]
14. Economic burden, work, and school productivity in individuals with tuberous sclerosis and their families.
Skalicky AM; Rentz AM; Liu Z; Said Q; Nakagawa JA; Frost MD; Wheless JW; Dunn DW
J Med Econ; 2018 Oct; 21(10):953-959. PubMed ID: 29890870
[TBL] [Abstract][Full Text] [Related]
15. Systemic onset juvenile idiopathic arthritis: a single center experience.
Sağ E; Uzunoğlu B; Bal F; Sönmez HE; Demir S; Bilginer Y; Özen S
Turk J Pediatr; 2019; 61(6):852-858. PubMed ID: 32134578
[TBL] [Abstract][Full Text] [Related]
16. Impact of caring for persons with Alzheimer's disease or dementia on caregivers' health outcomes: findings from a community based survey in Japan.
Goren A; Montgomery W; Kahle-Wrobleski K; Nakamura T; Ueda K
BMC Geriatr; 2016 Jun; 16():122. PubMed ID: 27287238
[TBL] [Abstract][Full Text] [Related]
17. Physician practices for withdrawal of medications in inactive systemic juvenile arthritis, Childhood Arthritis and Rheumatology Research Alliance (CARRA) survey.
Shenoi S; Nanda K; Schulert GS; Bohnsack JF; Cooper AM; Edghill B; Gillispie-Taylor MC; Goldberg B; Halyabar O; Mason TG; Ronis T; Schneider R; Vehe RK; Onel K;
Pediatr Rheumatol Online J; 2019 Jul; 17(1):48. PubMed ID: 31331351
[TBL] [Abstract][Full Text] [Related]
18. Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis.
Schulert GS; Minoia F; Bohnsack J; Cron RQ; Hashad S; KonÉ-Paut I; Kostik M; Lovell D; Maritsi D; Nigrovic PA; Pal P; Ravelli A; Shimizu M; Stanevicha V; Vastert S; Woerner A; de Benedetti F; Grom AA
Arthritis Care Res (Hoboken); 2018 Mar; 70(3):409-419. PubMed ID: 28499329
[TBL] [Abstract][Full Text] [Related]
19. Impact of age, sex, physical function, health-related quality of life, and treatment with adalimumab on work status and work productivity of patients with ankylosing spondylitis.
Maksymowych WP; Gooch KL; Wong RL; Kupper H; van der Heijde D
J Rheumatol; 2010 Feb; 37(2):385-92. PubMed ID: 19955052
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality-of-life, work productivity, and economic burden among patients with Parkinson's disease in Japan.
Yamabe K; Liebert R; Flores N; Pashos C
J Med Econ; 2018 Dec; 21(12):1206-1212. PubMed ID: 30200795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
